NCT05955027View on ClinicalTrials.gov

A Study to Evaluate the Effect of a Single Oral Dose of ZX-7101A on the QTc Interval in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 8, 2023

Primary Completion Date

August 5, 2023

Study Completion Date

December 15, 2023

Conditions
Influenza, Human
Interventions
DRUG

ZX-7101A

a drug to treat influenza, oral

DRUG

Placebo

placebo control, oral

Trial Locations (1)

Unknown

Huashan Hospital affiliated to Fudan University, Shanghai

Sponsors
All Listed Sponsors
lead

Nanjing Zenshine Pharmaceuticals

INDUSTRY